July 23, 2025

Supplementary Figure S2 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer

View Full Paper

Ask AI

Bookmark

Main finding indicates overall survival rates in advanced low PD-L1 non-small cell lung cancer patients vary by treatment.
Data from 851 patients show clear differences in progression-free survival based on various treatment options.
A comprehensive analysis was conducted on the prognostic factors that impact survival outcomes.
Understanding these outcomes enhances treatment strategies and clinical decision-making for lung cancer patients.

Implication

Findings reveal overall and progression-free survival in 851 patients, indicating key prognostic factors.

Overall survival and Progression-free survival of 851 patients according to treatments

No takes yet. Share an insight, caveat, or question.

Hata et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Findings reveal overall and progression-free survival in 851 patients, indicating key prognostic factors.

Overall survival and Progression-free survival of 851 patients according to treatments